The Therapeutic Goods Administration (TGA), the regulatory body for medical supplies in Australia, is responsible for carrying out a series of review and supervision work to ensure that the therapeutic goods provided in Australia meet its standards. As we know, Australia implements strict management on the production and import of drugs, and is recognized as one of the countries with strict drug management in the world.
In January 2022, TGA conducted a three-day video inspection of Tianjiang Pharmaceutical, including the company's plant facilities and equipment, material storage management, production process quality control, laboratory management, confirmation and verification and other aspects. At the end of the inspection, the inspector highly praised of the company's strict quality control system and professional and rigorous work performance.
Tianjiang Pharmaceutical successfully obtained the Australian TGA certification on April 5, 2022. The certification scope includes two dosage forms of hard capsules and granules. Passing the TGA certification means that Tianjiang Pharmaceutical has not only been recognized by the Australian government in terms of quality system and production environment facilities, but also by the PIC/S member countries, such as the United States, Canada, the United Kingdom, Germany, France, Italy, Austria, Belgium, Denmark, etc In addition, TGA and the European Union have also reached a mutual recognition agreement, which means that the conformity assessment certificate issued by TGA can also be recognized by the European Union, which further simplifies the process of overseas application and registration for Tianjiang Pharmaceutical.
Obtaining the TGA certification will play a positive role in promoting the development of international market for Tianjiang Pharmaceutical's, and also for the company's future development!
